To study the in vivo effects of PPARγ activation in immune-mediated hepatitis, in which the interplay between immune and non-immune cells is pivotal for liver injury, we analyzed the effect of pharmacologic PPARγ activation in the experimental hepatitis model based on the application of Galactosamine and LPS. Here, PPARG is linked to Hepatitis.